N.Y. Comp. Codes R. & Regs. tit. 10, § 58-2.19 – Records to be kept when derivatives are infused.

(a) product name, manufacturer, lot number, and expiration date;
(b) documentation of visual inspection prior to infusion;
(c) name of person administering the product;
(d) documentation of identification of the recipient;
(e) date of infusion and quantity of material infused; and
(f) description of any adverse reaction and the results of related investigation.

The following information shall be included on the recipient's chart or in records maintained in the blood bank or pharmacy: